tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRZN Stock Latest News

Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
Pre-EarningsSurrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
3d ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
29d ago
SRZN
Surrozen announces routine board resignation with no disputes
PremiumCompany Announcements
Surrozen announces routine board resignation with no disputes
2M ago
8K
SRZN
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
PremiumRatings
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
4M ago
SRZN
Surrozen initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Surrozen initiated with an Outperform at LifeSci Capital
4M ago
SRZN
Surrozen, Inc. Reports Significant Q3 2025 Loss
PremiumCompany AnnouncementsSurrozen, Inc. Reports Significant Q3 2025 Loss
4M ago
SRZN
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
Premium
Ratings
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
4M ago
SRZN
Surrozen Appoints Andrew Maleki as New CFO
Premium
Company Announcements
Surrozen Appoints Andrew Maleki as New CFO
4M ago
8K
SRZN
Surrozen names Andrew Maleki as CFO
PremiumThe Fly
Surrozen names Andrew Maleki as CFO
4M ago
SRZN
Surrozen’s Collaboration Agreement with TCGFB Terminated
PremiumCompany Announcements
Surrozen’s Collaboration Agreement with TCGFB Terminated
5M ago
8K
SRZN
Surrozen Signs $50M Sales Agreement with TD Securities
PremiumCompany Announcements
Surrozen Signs $50M Sales Agreement with TD Securities
7M ago
8K
SRZN
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
PremiumRatings
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
7M ago
SRZN
Surrozen’s Q2 2025: Progress in Eye Disease Therapies
PremiumCompany AnnouncementsSurrozen’s Q2 2025: Progress in Eye Disease Therapies
7M ago
SRZN
Surrozen files $150M mixed securities shelf
Premium
The Fly
Surrozen files $150M mixed securities shelf
10M ago
SRZN
Surrozen Holds Successful 2025 Annual Stockholders Meeting
Premium
Company Announcements
Surrozen Holds Successful 2025 Annual Stockholders Meeting
10M ago
8K
SRZN
Surrozen granted patent from USPTO directed to antibody-based molecules
PremiumThe Fly
Surrozen granted patent from USPTO directed to antibody-based molecules
10M ago
SRZN
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
PremiumRatings
Surrozen’s Strategic Focus on Wnt Pathway and Promising Pipeline Earns Buy Rating
10M ago
SRZN
Surrozen, Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
Surrozen, Inc. Reports Q1 2025 Financial Results
10M ago
SRZN
Surrozen files to sell 5.21M shares of common stock for holders
PremiumThe Fly
Surrozen files to sell 5.21M shares of common stock for holders
11M ago
SRZN
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating
PremiumRatingsSurrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating
12M ago
SRZN
Surrozen Focuses on Ophthalmology Amid Financial Challenges
Premium
Company Announcements
Surrozen Focuses on Ophthalmology Amid Financial Challenges
12M ago
SRZN
Surrozen reports FY24 EPS ($21.67) vs. ($21.33) last year
Premium
The Fly
Surrozen reports FY24 EPS ($21.67) vs. ($21.33) last year
12M ago
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >